Search Results

Prescription and administration of Oxygen in a Hospital or Clinic setting; Guidelines and Procedure (G22)

The aim of these guidelines are to ensure that: • All patients who require supplementary oxygen therapy receive therapy that is appropriate to their clinical condition and in line with national guidance (BTS Guideline; 2017). • Where oxygen saturation monitoring is available oxygen will be prescribed according to a target saturation range. • Those who administer oxygen therapy will monitor the patient and titrate oxygen to maintain oxygen saturations within the target saturation range.

Inpatient Falls Prevention and Management Policy (P33)

The Trust’s aim is to prevent harm resulting from in-patient falls by assessing each patient individually and identifying their risk in order to develop a care plan to reduce these risks. There is an expectation that clinicians will use the policy framework within everyday practice within DCHS. DCHS Inpatient services are part of the DCHS Falls and Fracture Prevention framework which contributes towards the wider Derbyshire and Derby City Falls and Fracture Prevention Pathway in identifying and managing patients who are at risk of falls in hospital and onwards as part of discharge plans and communication. This policy incorporates guidance from the: - • NICE CG161(2013) “Falls: the assessment and prevention of falls in older people • National Patient Safety Agency (2011) on “Essential care after an inpatient fall” • NICE (2015) on “Head Injury: assessment and early management” The purpose of this policy is to support staff to identify patients who are at risk of falling and to identify the interventions required to reduce the risk of falls and minimise harm to each individual. This policy also provides guidance on how to implement the NICE Quality standards (2015) ‘Assessment after a fall and preventing further falls’

Administration of Methylprednisolone Acetate Injection SOP for Podiatrists (Depo-Medrone +- Lidocaine) (S93)

Guidance on the appropriate and safe administration of the corticosteroid injections exempted under podiatry POM-A

Smallpox Vaccine for Mpox– Receiving Delivery, Unpacking of Frozen Vaccine and Transfer to Fridges to Thaw Standard Operating Procedure (S97)

As part of the national response to the monkeypox incident, DCHS will be receiving frozen smallpox vaccine (currently Imvanex and Jynneos, may be alternative brand in future) the modified vaccinia Ankara (MVA-BN) to be able to vaccinate appropriate people in line with national guidance. This SOP describes the process of receiving a delivery of the smallpox vaccine, unpacking frozen smallpox vaccine and transfer into a fridge to thaw.

Patient Initiated Follow-Up SOP for Community Therapy (S126)

Patient Initiated Follow-Up SOP for Community Therapy

A6 – Competency framework for podiatry assistants – wound care (S107)

Competency framework for podiatry assistants – wound care

Patient (or carer) Initiated Follow-up SOP Dementia Palliative Care Service (S132)

Patient initiated follow-up (PIFU) describes when a patient (or their carer) can initiate their follow-up visit as and when required, e.g., when symptoms or circumstances change. This SOP defines the process, roles, and responsibilities for the following: • Identifying which patients PIFU is right for • Moving a patient onto a PIFU pathway • Booking visits which have been initiated by a patient or carer • Managing patients who do not initiate a review/home visit within the PIFU timescale • Discharging or booking reviews at the end of that patient’s PIFU timescale • Monitoring compliance Dementia Palliative Care Service are in the process of piloting a PIFU process for 12 months. The pilot will be reviewed every 3 months with a final review post 12 months.

Final Standard Operating Procedure Safe Staffing Levels and Annual Leave management ISHS October 2025

Disclosure Ref 2025218 - Vehicle fleet list operated by the Trust, whether owned or leased.doc

Freedom of information disclosure relating to vehicle fleet list operated by the Trust, whether owned or leased

Disclosure Ref 2025262- Damp and mould health related conditions January 2022 to January 2025.doc

Freedom of information request relating to yearly figures (2022–2024) on diagnoses, admissions, and deaths related to damp‑ and mould‑associated conditions—including aspergillosis, hypersensitivity pneumonitis, and allergic bronchopulmonary aspergillosis—within the period 1 January 2022 to 1 January 2025.